Tuesday, September 04, 2018 7:54:00 PM
New website is amazing
https://vr-whsi.com/about-the-industry
5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On August 31, 2018, Wearable Health Solutions . (the “Company” or (WHSI) has accepted the resignation of Ron Adams Alan Polsky Jennifer Loria effectively all officers’ directors and board members. (Controlling Group).
WHSI has appointed interim management Daniel Sobolewski as Interim President and CEO Irina Veselinovic as interim Secretary and Treasurer.
The Company has relocated its offices from 200 West Church Road, Suite B, King of Prussia, PA 19406 to 224 Datura Street # 12015 (W) West Palm Beach Florida 33401. The Company new telephone number is: 1(800) 913-6149.
The Company new web site is www.VR-WHSI.Com.
The Company new Twitter Social Media Handle is: @VWHSI Twitter.com/VWHSI
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 Unregistered Sales of Equity Securities
The interim management mandate is to conduct a corporate restructuring of the company and settle all debts and warrants. Additionally, new interim management mandate is to restore shareholder value and seek out other opportunities and ventures.
The company has commenced integration and development of various wearable health type products that utilize the virtual reality technology (VR). The company intends to integrate the VR with the new line of wearable products to offer a unique zen state type of experience for relief of stress headaches and muscle aches.
On August 31, 2018, WHSI interim management sold the bulk of its assets consisting of hearing aid devices and lines of product associated with hearing aid line of products only. The consideration accepted was the exchange of 28,000,000 shares of WHSI owned by the Controlling Group, to Aqualaro Corporation. The transaction was concluded in accordance and as part of an asset purchase and sale agreement.
The interim management passed a resolution to change the Company business direction model from hearing aid supplemental device supplier to a full service VR and Health Related Product lines distributor and dealer.
The Company issued 3,500,000 Restricted Rule 144 shares to an investor in exchange for a $25,000.00 one time investment. The new interim management has settled all notes and debts owed by the company to the previous management and or Controlling Group in exchange for 2,634,164 restricted shares. The company secured a $50,000 line of credit from EMRY CAPITAL bearing interest at 8 % Per annum secured by company stock (convertible note) convertible as per default provisions. The Company has earmarked these funds exclusively towards the successful VR product line development and integration.
Recent WHSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 09:52:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 04:04:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:44:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:01:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 08:02:04 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/20/2023 08:28:54 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:11:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:10:15 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM